GE Healthcare, TRAM MODULE, High-acuity patient monitoring
Medical device recall Z-0808-2014. Published in FDA’s Enforcement Report on Jan 29, 2014.
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on Jan 29, 2014. Copied from openFDA on Oct 20, 2026.
- Class II FDA’s class
- Terminated its status, in FDA’s file
- Nationwide FDA’s word, and 2 states named
- 1,948 (1,834 US; 114 OUS) how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class II, the middle of FDA’s three classes.
“Products that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.”
openFDA, in plain words, its enforcement report fields.
“Class II is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
FDA’s rule, 21 CFR 7.3(m)(2), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
Intermittent noise on ECG and/or Respiration waveforms associated with movement of the ECG cable connector on the DASH, PDM, and/or Tram Module. May result in reduced ECG, Respiration and arrhythmia detection performance.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
GE Healthcare, TRAM MODULE, High-acuity patient monitoring. Product Usage: The TRAM Module is intended to provide uninterrupted monitoring of physiologic parameter data on adult, pediatric and neonatal patients during transport from one area of the hospital or facility, and monitoring system, to another. K900540: TRAM modules are intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use. The intended use of TRAM modules is to provide uninterrupted monitoring of physiologic parameter data on adult, pediatric and neonatal patients during transport from one area of the hospital or facility, and monitoring system, to another. The TRAM module functions as a transport monitor during transport, and in the bedside monitor during ICU or OR monitoring. Physiological parameter data includes ECG, invasive blood pressure, non-invasive blood pressure, pulse oximetry, cardiac output, temperature, and respiration. TRAM modules acquire, process and store information regarding these parameters. TRAM modules incorporate different monitoring capabilities based on their configuration. K011000: The TRAM 2001 Module is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use. The TRAM 2001 Module is intended to provide uninterrupted monitoring of physiologic parameter data on adult, pediatric, and neonatal patients during transport from one area of the hospital or facility, and monitoring system, to another. During non-transport monitoring, the TRAM 2001 Module functions in the bedside monitoring system. Physiological parameter data includes ECG, invasive blood pressure, non-invasive blood pressure, pulse oximetry, cardiac output, temperature, and respiration. The TRAM 2001 Module acquires, processes and stores information regarding these parameters. The device is intended for use in a professional medical facility, such as hospital, clinic, surgical center or doctors office. The TRAM System can be used in multiple areas such as operating room (OR), post anesthesia recovery (PARR), critical care, surgical intensive care, coronary care, medical intensive care, pediatric intensive care, or neonatal intensive care. The device is intended for use as part of a transport monitoring system for intra-hospital transport. K053121: The TRAM Module is intended for use under the direct supervision of a licensed healthcare practitioner, or by personnel trained in its proper use. The TRAM Module is intended to provide uninterrupted monitoring of physiologic parameter data on adult, pediatric and neonatal patients during transport from one area of the hospital or facility, and monitoring system, to another. During non-transport monitoring, the TRAM Module functions in the bedside monitoring system. Physiological parameter data includes ECG, invasive blood pressure, non-invasive blood pressure, non-invasive blood pressure, pulse oximetry, cardiac output, temperature and respiration. The TRAM Module acquires, processes and stores information regarding these parameters. The device is intended for use in a professional medical facility, such as hospital, clinic, surgical center or doctors office. The TRAM System can be used in multiple areas such as operating room (OR), post anesthesia recovery (PARR), critical care, surgical intensive care, pediatric intensive care, or neonatal intensive care. The device is intended for use as part of a transport monitoring system for intra-hospital transport.
1,948 (1,834 US; 114 OUS), in FDA’s words.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
Serial Number C7HA1686G C7HA1700G C7HA1701G C7HA1696G C7HA1692G C7HA1688G C7HA1691G C7HA1689G C7HA1687G C7HA1702G B7HA1657G C7HA1683G C7HA1703G C7HA1707G C7HA1709G C7HA1711G D8HA3141G D8HA3154G D8HA3135G D8HA3136G D8HA3149G D8HA3148G…
Every code shown here, 1,994 characters
Serial Number C7HA1686G C7HA1700G C7HA1701G C7HA1696G C7HA1692G C7HA1688G C7HA1691G C7HA1689G C7HA1687G C7HA1702G B7HA1657G C7HA1683G C7HA1703G C7HA1707G C7HA1709G C7HA1711G D8HA3141G D8HA3154G D8HA3135G D8HA3136G D8HA3149G D8HA3148G D8HA3128G D8HA3134G D8HA3152G D8HA3140G D8HA3137G D8HA3144G H3S20070G H3S20072G J3S20073G J3S20075G J3S20078G J3S20084G J3S20089G J3S20090G J3S20093G J3S20085G A4S20482G A4S20471G G4S21111G G4S21108G G4S21112G G4S21090G G4S21106G F5HB0489G E5HB0418G F5HB0493G F5HB0491G F5HB0468G F5HB0497G F5HB0478G E5HB0459G C5HB0346G B5HB0261G A6HB0980G A6HB0978G D6HB1379G K7HB4546G K7HB4542G K7HB4552G K7HB4553G K7HB4547G K7HB4556G C8HB5556G C8HB5743G C8HB5744G C8HB5758G C8HB5747G C8HB5746G C8HB5750G C8HB5756G C8HB5757G C8HB5676G D8HB5922G G8HB6864G G8HB6859G B9HA4387G B9HA4403G B9HA4405G B9HA4402G F8HB6464G L4HB0063G L4HB0068G L4HB0064G M4HB0151G M4HB0143G A5HA0120G A5HA0118G A5HA0125G A5HA0122G A5HA0112G A5HA0117G A5HA0111G A5HA0119G A5HA0109G A5HA0114G A5HA0124G L4HC0003G H5HA0362G H5HA0367G D6HB1475G D6HB1467G D6HB1455G D6HB1458G D6HB1442G D6HB1469G D6HB1430G D6HB1465G D6HB1435G D6HB1476G D6HB1440G D6HB1463G D6HB1439G D6HB1438G D6HB1461G D6HB1460G M6HD8751F M6HD8723F M6HD8732F M6HD8683F M6HD8749F M6HD8725F M6HD8748F M6HD8728F M6HD8737F M6HD8730F M6HD8750F M6HD8726F M6HD8747F M6HD8724F M6HD8736F M6HD8744F M6HD8740F M6HD8731F M6HD8745F M6HD8722F M6HD8739F M6HD8741F M6HD8742F M6HD8738F M6HD8746F A7HA1527G A7HA1564G A7HA1550G A7HA1546G A7HA1562G A7HA1529G A7HA1561G A7HA1563G A7HA1560G B7HA1598G B7HA1595G B7HA1583G B7HA1579G B7HA1591G B7HB2686G B7HB2694G B7HB2676G F7HB3564G F7HB3571G F7HB3561G F7HB3567G F7HB3499G F7HB3498G F7HB3526G F7HB3511G F7HB3516G F7HB3536G F7HB3537G F7HB3538G F7HB3541G F7HB3534G F7HB3533G F7HB3539G F7HB3532G F7HB3535G F7HB3548G F7HB3540G F7HB3589G F7HB3556G G7HB3740G G7HB3773G G7HB3772G G7HB3774G G7HB3747G G7HB3769G G7HB3775G G7HB3748G G7HB3766G G7HB3746G G7HB3735G G7HB3741G G7HB3726G H7HB4010G C8HB5492G C8HB5488G C8HB5481G…
FDA’s list runs to 23,185 characters. The first part is shown; the rest is on FDA’s record.
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
Worldwide Distribution: US (nationwide) including DC and PR except SD, VT and WY; and Internationally to: ARGENTINA, AUSTRALIA, AUSTRIA, BAHRAIN, BELGIUM, BRAZIL, CHINA, COLOMBIA, COSTA RICA, CROATIA, CZECH REPUBLIC, EGYPT, GERMANY, UNITED KINGDOM, IRELAND, IRAQ, ISRAEL, JAMAICA, JAPAN, JORDAN, KOREA, KUWAIT, LEBANON, LITHUANIA, MARITIUS, MALDOVA, NEW ZEALAND, NIGERIA, PAKISTAN, PANAMA, PARAGUAY, PERU, POLAND, QATAR, RUSSIA, SLOVAKIA, SOUTH AFRICA, SWEDEN, SWITZERLAND, TUNISIA, UNITED ARAB EMIRATES, VENEZUELA, CHILE, CANADA, and BERMUDA.
The states and territories these words name
- District of Columbia
- Puerto Rico
They leave out South Dakota, Vermont and Wyoming.
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
The words say it went outside the United States too.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on Dec 5, 2013.
- FDA classified it on Jan 22, 2014.
- FDA’s Enforcement Report published it on Jan 29, 2014.
- FDA terminated it on Jul 25, 2016.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- GE Healthcare, LLC, of Waukesha, WI.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- FDA’s list of codes runs to 23,185 characters; the first part is shown here, and the rest is on FDA’s record.
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Device recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.